Loading clinical trials...
Loading clinical trials...
Feasibility Study of the Use of Ultra-low Dose Iodinated Contrast Agent for Endovascular Procedures in Patients With Chronic Limb-threatening Ischemia and Renal Impairment
Conditions
Interventions
Infrainguinal peripheral endovascular revascularization
Locations
1
Greece
"ATTIKON" University General Hospital, , 1st Rimini St,
Chaïdári, Attica, Greece
Start Date
September 1, 2024
Primary Completion Date
January 23, 2026
Completion Date
January 23, 2026
Last Updated
March 10, 2026
NCT07154901
NCT05830721
NCT07165015
NCT06352411
NCT07445906
NCT03289208
Lead Sponsor
Attikon Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions